Gonzalo J A, González-García A, Baixeras E, Zamzami N, Tarazona R, Rappuoli R, Martínez C, Kroemer G, Tarazona R, Terezone R
National Center of Biotechnology, CSIC, Autónoma University of Madrid, Spain.
J Immunol. 1994 May 1;152(9):4291-9.
Intravenous injection of a bacterial superantigen such as Staphylococcus aureus enterotoxin B (SEB) causes transient activation and expansion of SEB-reactive V beta 8+ T cells, as well as specific down-regulation of the immune response, through partial deletion of superantigen-reactive T cells. Here we demonstrate that co-administration of pertussis toxin (PTX) and SEB reduces the SEB-induced deletion of V beta 8+ T cells, although it does not affect T cell activation and proliferation. PTX abrogates the SEB-driven deletion of V beta 8+CD4+ (not V beta 8+CD8+) splenocytes that is observed early (12-24 h) after SEB injection. Moreover, it antagonizes the late (> or = 4 days) deletion of V beta 8+CD4+ and V beta 8+CD8+ peripheral T cells that follows transient expansion of such cells. This phenomenon is associated with significant reductions in apoptosis and endonucleolysis and is not caused by a compensatory increase in proliferation of SEB-reactive T cells, as we determined by using a combined fluorometric analysis of cell cycle and DNA alterations, which are associated with programmed cell death. These effects are also observed in thymectomized animals, thus excluding the possibility that PTX might act by enhancing the maturation and export of thymic T cells to the periphery. Moreover, the SEB-induced reduction of V beta 8+ splenocytes is antagonized by PTX in vitro. The capacity of PTX to reduce clonal deletion depends critically on its ADP-ribosyltransferase activity, inasmuch as a non-enzymatic PTX mutant fails to act in this biologic system. We conclude that PTX selectively antagonizes or impedes the delivery of negative signals to T cells, which are stimulated by superantigens, without interfering with the transmission of stimulatory signals.
静脉注射细菌超抗原,如金黄色葡萄球菌肠毒素B(SEB),会导致SEB反应性Vβ8 + T细胞短暂激活和扩增,以及通过部分清除超抗原反应性T细胞而使免疫反应发生特异性下调。在此我们证明,百日咳毒素(PTX)与SEB共同给药可减少SEB诱导的Vβ8 + T细胞缺失,尽管它不影响T细胞激活和增殖。PTX可消除SEB注射后早期(12 - 24小时)观察到的SEB驱动的Vβ8 + CD4 +(而非Vβ8 + CD8 +)脾细胞缺失。此外,它还能拮抗此类细胞短暂扩增后发生的晚期(≥4天)Vβ8 + CD4 +和Vβ8 + CD8 +外周T细胞缺失。这种现象与凋亡和核酸内切酶活性的显著降低相关,并非由SEB反应性T细胞增殖的代偿性增加所致,这是我们通过对与程序性细胞死亡相关的细胞周期和DNA改变进行联合荧光分析所确定的。在胸腺切除的动物中也观察到了这些效应,从而排除了PTX可能通过增强胸腺T细胞成熟并向外周输出而起作用的可能性。此外,PTX在体外可拮抗SEB诱导的Vβ8 +脾细胞减少。PTX减少克隆缺失的能力关键取决于其ADP - 核糖基转移酶活性,因为非酶促PTX突变体在此生物系统中不起作用。我们得出结论,PTX选择性拮抗或阻碍向受超抗原刺激的T细胞传递负信号,而不干扰刺激信号的传递。